Microvessel density as a prognostic factor in preinvasive and invasive cervical lesions

Objective: To assess angiogenesis in preinvasive and invasive cervical lesions and its prognostic value in squamous cell carcinoma (SCC).

Methods: Twenty-seven cervical intraepithelial lesions (CIN I, II and III), 27 Stage Ib-IIa SCC and 12 normal cervical epithelium were included in the study. Clinico-pathological prognostic factors were re-evaluated from the patients' files and previous tissue sections. Microvessel density (MVD), a marker for angiogenesis, was assessed from new tissue blocks by an immunohistochemical staining method. Statistical tests included Kruskall-Wallis analysis, the Mann-Whitney U-test, Fisher's exact t-test to analyse the categorical data and Cox regression and Kaplan-Meier survival analyses to define the effect of prognosticators on survival.

Results: CIN II and III lesions had significantly higher MVD counts than normal epithelium and CIN I lesions, both of which had similar MVD count. Compared to preinvasive lesions invasive SCC had significantly higher MVD counts. Among SCC cases, only pelvic lymph node involvement appeared to be independent risk factor on unvariate analysis. However, MVD, as a cut-off value of 21 determined by ROC analysis, was found to be an independent prognosticator in early stage SCC cases by multivariate analysis.

Conclusion: Despite the small number of enrolled cases, the results of this study suggest that angiogenesis involved in the development and progression of cervical neoplasms and MVD might be used as a prognostic factor.

Cervical intraepithelial neoplasia; Cervical cancer; Angiogenesis; Microvessel density

[1] Abolafia O., Sherer D.M.: "Angiogenesis of the endometrium". Obstet. Gynecol., 1999, 94, 148.

[2] Abolafia O., Triest W., Sherer W.: "Angiogenesis of the ovary" Am. J. Obstet. Gynecol., 2000, 182, 240.

[3] Folkman J.: "Tumor angiogenesis". Advances in Cancer Research, 1985, 43, 175.

[4] Abolafia 0., Triest W., Sherer D.M.: "Angiogenesis in mahgnancies of the female genital tract". Gynecol. Oncol., 1999, 72, 220.

[5] Wei L.H., Kuo M.L., Chen C.A. et al.: "Interleukin-6 in cervical cancer: the relationship with vascular endothelial growth factor". Gynecol. Oncol., 2001, 82, 49.

[6] Cabanillas-Saez A., Schalper J.A., Nicovani S.M., Rudolph M.I. : " Characterisation of mast cells according to their content of tryptase and chymase in normal and neoplastic human uterine cervix". Int. J. Gynecol. Cancer, 2002, 12, 92.

[7] Weidner N., Semple J.P., Welch W.R., Folkman J.: "Tumor angiogenesis and metastasis correlation in invasive breast carcinoma". New Engl J. Med., 1991, 324, 1.

[8] Garozzo G., Caragliano L., Consalvo P., Torrisi A.M., Caschetto S.: "Impact of neoangiogenesis on the survival of patients with Stage lb-lib cervical carcinoma". Minerva Ginecol., 2000, 52, 73.

[9] Pilsch H., Schaeffer U., Schlenger K. et al.: "Angiogenesis in cervical cancer". Gynecol. Obstet. Fertil., 2000, 28, 29.

[10] Smith-McKune K.K.,Weidner N.: "Demonstration and charactensation of the angiogenic properties of cervical dysplasias". Cancer Res., 1994, 54, 800.

[11] Dobbs S.P., Hewett P.W., Johnson I.R., Carmichael J., Murray J.C.: "Angiogenesis is associated with vascular endothelial growth factor expression in cervical intraepithelial neoplasia". Br. J Cancer, 1997, 76, 1410.

[12] Dellas A., Moch H., Schulteiss E., Feichter G. et al.: "Angiogenesis in cervical neoplasia: microvessel quantitation in precancerous lesions and invasive carcinomas with clinicopathological correlations". Gynecol. Oncol., 1997, 67, 27.

[13] Tjalma W., Marck E.V., Weyler J. et al.: "Quantification and prognostic relevance of angiogenic parameters in invasive cervical cancer". Br. J. Cancer, 1998, 78, 170.

[14] Kodama J., Hashimoto I., Seki N. et al.: "Thrombostin I and -2 messenger RNA expression in invasive cervical cancer:correlation with angiogenesis and prognosis". Clin. Cancer Res., 2001, 7, 2826.

[15] Bremer G.L., Tiebosch A.T.M.G., Van der P utten H.W.H.M., Schouten HJ.A., Haan J., Arends J.W.: "Tumor angiogenesis is an independent prognostic parameter in cervical cancer". Am. J Obstet. Gynecol., 1996, 174, 126.

[16] Wiggins D.L., Granai C.O., Steinhoff M.M., Clabresi P.: "Tumor angiogenesis as a prognostic factor in cervical carcinoma". Gynecol. Oncol., 1995, 56, 353.

[17] Hockel M., Vaupel P.: "Biologic consequences of tumor hypoxia" Semin. Oncol., 2001, 28, 36.

[18] Fyles A., Milosevic M., Hedley D. et al.: "Tumor hypoxia has independent predictor impact only in patients with node negative cervix cancer". J. Clin. Oncol., 2002, 20, 610.

[19] Vaupel P., Kelleher D.K., Hockel M.: "Oxygen status of malignant tumors: pathogenesis of hypoxia and significance for tumor therapy". Semin. Oncol., 2001, 28, 29.

[20] Mayr N.A., Yuh W.T., Oberley W., Spitz D., Sorosky J.I., Buatti J.M.: "Serial changes in tumor oxygenation during the early phase of radiation therapy in cervical cancer-are we quantitating hypoxia change?". Int. J. Radiat. Oncol. Biol. Phys., 2001, 49, 282.